Matthew J. Oborski

788 total citations
12 papers, 316 citations indexed

About

Matthew J. Oborski is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Matthew J. Oborski has authored 12 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 9 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Matthew J. Oborski's work include Medical Imaging Techniques and Applications (8 papers), Glioma Diagnosis and Treatment (7 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Matthew J. Oborski is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), Glioma Diagnosis and Treatment (7 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Matthew J. Oborski collaborates with scholars based in United States, Qatar and Canada. Matthew J. Oborski's co-authors include James M. Mountz, Frank S. Lieberman, Rafay Ahmed, Misun Hwang, Charles M. Laymon, Jan Drappatz, Ronald L. Hamilton, Yongxian Qian, Bennett Van Houten and Jennifer R. Grandis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Matthew J. Oborski

11 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew J. Oborski United States 8 157 132 112 75 40 12 316
Theophilos Tzaridis Germany 13 235 1.5× 118 0.9× 156 1.4× 97 1.3× 46 1.1× 27 401
Pavlina Polaskova United States 7 185 1.2× 148 1.1× 110 1.0× 107 1.4× 70 1.8× 8 399
Abraham Boskovitz United States 7 127 0.8× 98 0.7× 123 1.1× 80 1.1× 84 2.1× 8 352
Giulia Cerretti Italy 10 281 1.8× 73 0.6× 107 1.0× 77 1.0× 66 1.6× 30 402
Toni Rose Jue Australia 9 153 1.0× 39 0.3× 103 0.9× 62 0.8× 52 1.3× 16 311
Ryan Merrell United States 10 146 0.9× 60 0.5× 47 0.4× 51 0.7× 89 2.2× 35 261
Si Gui China 4 195 1.2× 61 0.5× 203 1.8× 198 2.6× 25 0.6× 6 357
Guo-Shi Lin China 10 164 1.0× 88 0.7× 183 1.6× 150 2.0× 84 2.1× 12 408
Daniel Xia United States 10 203 1.3× 93 0.7× 264 2.4× 112 1.5× 72 1.8× 29 529
J.A. MacKinnon Canada 3 232 1.5× 69 0.5× 76 0.7× 79 1.1× 50 1.3× 3 315

Countries citing papers authored by Matthew J. Oborski

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Oborski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Oborski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Oborski more than expected).

Fields of papers citing papers by Matthew J. Oborski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Oborski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Oborski. The network helps show where Matthew J. Oborski may publish in the future.

Co-authorship network of co-authors of Matthew J. Oborski

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Oborski. A scholar is included among the top collaborators of Matthew J. Oborski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Oborski. Matthew J. Oborski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Smith, Bruce A., John M. Buatti, Christian Bauer, et al.. (2020). Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer Images. Tomography. 6(2). 65–76. 4 indexed citations
2.
Laymon, Charles M., Davneet Minhas, Carl Becker, et al.. (2018). Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging. Molecular Imaging and Biology. 20(5). 826–834.
3.
Oborski, Matthew J., Charles M. Laymon, Frank S. Lieberman, et al.. (2016). [18F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment. Tomography. 2(4). 317–324. 6 indexed citations
4.
5.
Nakajima, Erica C., Charles M. Laymon, Matthew J. Oborski, et al.. (2014). Quantifying Metabolic Heterogeneity in Head and Neck Tumors in Real Time: 2-DG Uptake Is Highest in Hypoxic Tumor Regions. PLoS ONE. 9(8). e102452–e102452. 24 indexed citations
6.
Mountz, James M., Rafay Ahmed, Matthew J. Oborski, Frank S. Lieberman, & Misun Hwang. (2014). Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Management and Research. 6. 149–149. 169 indexed citations
7.
Oborski, Matthew J., Charles M. Laymon, Frank S. Lieberman, et al.. (2014). First use of 18F‐labeled ML‐10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy. Brain and Behavior. 4(2). 312–315. 38 indexed citations
8.
Oborski, Matthew J., Emre Demirci, Charles M. Laymon, Frank S. Lieberman, & James M. Mountz. (2013). Assessment of Early Therapy Response with 18F-FLT PET in Glioblastoma Multiforme. Clinical Nuclear Medicine. 39(10). e431–e432. 7 indexed citations
9.
Oborski, Matthew J., Charles M. Laymon, Frank S. Lieberman, & James M. Mountz. (2013). Distinguishing Pseudoprogression From Progression in High-Grade Gliomas. Clinical Nuclear Medicine. 38(5). 381–384. 9 indexed citations
10.
Laymon, Charles M., Matthew J. Oborski, Vince Lee, et al.. (2012). Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis. Magnetic Resonance Imaging. 30(9). 1268–1278. 24 indexed citations
11.
Lotze, Michael T., Leonard J. Appleman, Ramesh K. Ramanathan, et al.. (2012). Phase I study of intravenous PI3K inhibitor BAY 80-6946: Activity in patients (pts) with advanced solid tumors and non-Hodgkin lymphoma treated in MTD expansion cohorts.. Journal of Clinical Oncology. 30(15_suppl). 3019–3019. 9 indexed citations
12.
Patnaik, Amita, Ramesh K. Ramanathan, Leonard J. Appleman, et al.. (2012). Phase I Study of Intravenous PI3K Inhibitor Bay 80–6946: Preliminary Activity in Patients with Relapsed Non-Hodgkin Lymphoma (NHL) Treated in an MTD Expansion Cohort. Blood. 120(21). 3704–3704. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theophilos Tzaridis Breakdown of academic impact, for papers by Pavlina Polaskova Breakdown of academic impact, for papers by Abraham Boskovitz Breakdown of academic impact, for papers by Giulia Cerretti Breakdown of academic impact, for papers by Toni Rose Jue Breakdown of academic impact, for papers by Ryan Merrell Breakdown of academic impact, for papers by Si Gui Breakdown of academic impact, for papers by Guo-Shi Lin Breakdown of academic impact, for papers by Daniel Xia Breakdown of academic impact, for papers by J.A. MacKinnon
Rankless by CCL
2026